Exane Derivatives’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,180
Closed -$175K 947
2021
Q3
$175K Sell
4,180
-326
-7% -$11.7K 0.04% 427
2021
Q2
$165K Buy
4,506
+348
+8% +$12.4K 0.04% 449
2021
Q1
$142K Buy
4,158
+200
+5% +$8.53K 0.04% 345
2020
Q4
$180K Buy
3,958
+813
+26% +$28.4K 0.05% 324
2020
Q3
$86.5K Buy
3,145
+431
+16% +$14.1K 0.03% 322
2020
Q2
$100K Buy
2,714
+2,700
+19,286% +$101K 0.03% 296
2020
Q1
$453 Hold
14
﹤0.01% 612
2019
Q4
$666 Hold
14
﹤0.01% 584
2019
Q3
$498 Hold
14
﹤0.01% 585
2019
Q2
$719 Hold
14
﹤0.01% 575
2019
Q1
$802 Sell
14
-252
-95% -$12.5K ﹤0.01% 513
2018
Q4
$11.2K Hold
266
﹤0.01% 456
2018
Q3
$20.7K Sell
266
-3,734
-93% -$269K ﹤0.01% 416
2018
Q2
$284K Hold
4,000
0.05% 225
2018
Q1
$114K Buy
+4,000
New +$116K 0.02% 284

Other funds holding RGNX